OncoImmune
ID: 5329569A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
5
Funding Rounds
$76.5m
Money raised
Recent Funding Rounds
Overview
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company OncoImmune has raised a total of $20.5m in funding over 5 rounds.
Key Insights:
- OncoImmune, Inc. funding round, April 2020: $1.5m
- OncoImmune Grant (money), July 2018: $2m
- OncoImmune Grant (money), September 2017: $2m
- OncoImmune Series A round, January 2017: $15m
- OncoImmune Series B round September 2020: $56m
Industries
OncoImmune is active in the following industries: